NCT05775965View on ClinicalTrials.gov

HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)

PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 1, 2026

Conditions
Hip Fractures
Interventions
DRUG

Rivaroxaban 10mg

Rivaroxaban 10mg daily for 35 days post hip fracture surgery

DRUG

acetylsalicylic acid (ASA) 81mg Oral Tablet

acetylsalicylic acid (ASA) 81mg daily for 35 days post hip fracture surgery

Trial Locations (3)

T2N 5A1

RECRUITING

Foothills Medical Centre, Calgary

V3L 0E4

NOT_YET_RECRUITING

Royal Columbian Hospital, New Westminster

Unknown

NOT_YET_RECRUITING

The Ottawa Hospital, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Calgary

OTHER